Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT
Clinical trial NCT05820100 · COMPLETED
Trial details
- NCT number
- NCT05820100
- Sponsor
- Nanoscope Therapeutics Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-04-25
- Primary completion
- 2023-10-17
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.